Context Thyroid cancer recurrence is associated with increased mortality and adverse
outcomes. Recurrence risk is currently predicted using clinical tools, often restaging patients …

Background Recurrence of papillary thyroid cancer is not uncommon, but incorporating
clinicopathologic parameters to predict recurrence is suboptimal. The aim of this study was …

The papillary thyroid carcinoma (PTC) usually shows an excellent prognosis. But some
patients suffer recurrence after treatment. Recent progress in RNA sequencing (RNA-Seq) …

Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer (TC). In a
subgroup of patients with PTC, the disease progresses to an invasive stage or in some …

Purpose Identification of stage-specific prognostic/predictive biomarkers in papillary thyroid
carcinoma (PTC) could lead to its more efficient clinical management. The main objective of …

As the importance of personalized therapeutics in aggressive papillary thyroid cancer (PTC)
increases, accurate risk stratification is required. To develop a novel prognostic scoring …

Purpose Although papillary thyroid cancer (PTC) has a low mortality rate, the rate of
recurrence remains relatively high. This study aims to develop a molecular signature to …

Simple Summary The three-tiered American Thyroid Association (ATA) risk stratification
helps clinicians tailor decisions regarding follow-up modalities and the need for …

Background Although most papillary thyroid carcinoma (PTC) cases have a good prognosis,
some PTCs are more aggressive and are often accompanied by lymph node (LN) …

Although the majority of papillary thyroid cancer (PTC) is indolent, a subset of PTC behaves
aggressively despite the best available treatment. A major clinical challenge is to reliably …